Your Health, We Care
1. Cardiovascular Toxicity
2. Pulmonary Hypertension
3. Bleeding Risk
4. Pulmonary Toxicity
FDA，2021.10
Anagrelide is indicated to reduce the risk of blood clots in patients with throm···【more】
Release date：2026-01-30Recommended：43
Anagrelide may cause a range of side effects during use.What side effects may An···【more】
Release date：2026-01-30Recommended：39
